alkenes has been researched along with Cognition Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geng, Y; Han, B; Shen, L; Wang, J; Wang, M; Wang, Z | 1 |
| An, C; Chen, Q; Jia, L; Li, Y; Wang, M; Wang, S; Yu, L; Zhen, F | 1 |
2 other study(ies) available for alkenes and Cognition Disorders
| Article | Year |
|---|---|
Amelioration of cognitive impairments in APPswe/PS1dE9 mice is associated with metabolites alteration induced by total salvianolic acid.
Topics: Alkenes; Amyloid beta-Protein Precursor; Animals; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Cognition Disorders; Cognitive Dysfunction; Enzyme-Linked Immunosorbent Assay; Gas Chromatography-Mass Spectrometry; Hippocampus; Male; Mice; Mice, Inbred C57BL; Polyphenols; Triglycerides | 2017 |
Combination Therapy of Salvianolic Acid and Fluoxetine Improves the Cognitive Function of Rats with Chronic Stress-induced Depression.
Topics: Alkenes; Animals; Antidepressive Agents, Second-Generation; Chronic Disease; Cognition Disorders; Depressive Disorder; Disease Models, Animal; Drug Therapy, Combination; Fluoxetine; Male; Maze Learning; Polyphenols; Rats; Rats, Sprague-Dawley; Stress, Psychological | 2016 |